Epredia
4481 Campus Drive, Kalamazoo, MI, 49008, United States
Overview
Epredia has a wide breadth of solutions that have and will continue to transform the anatomical pathology market.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Biotechnology
- Health Care
- Health Diagnostics
Investment portfolio
- Aiforia
Led · Series B · Jun 2021
Aiforia builds a deep learning AI platform that analyzes ultra-high-resolution biopsy images to assist pathologists in identifying cancer cells more quickly and precisely. The company has created thousands of AI models for research and provides CE-IVD marked AI solutions used in healthcare and research environments in Europe and worldwide. Aiforia positions its technology to improve diagnostic capabilities, support medical research, and enable earlier and more accurate disease detection. The company plans to continue developing new and existing AI-powered image analysis solutions and to expand its commercial presence internationally. Financially, Aiforia recently secured €20 million in venture debt from the European Investment Bank, structured in tranches with milestone-based access and a synthetic warrant arrangement.
Team
No current team members are available.